Warning letter
Unit Dose Packaging, Inc.: warning letter of Aug 29, 2002
FDA warning letter UCM145091 · Los Angeles District Office
Key facts
| Reference number | UCM145091 |
|---|---|
| Company | Unit Dose Packaging, Inc. |
| Subject | Current Good Manufacturing Practices for Finished Pharmaceuticals/Adulterated |
| Issue date | Aug 29, 2002 |
| Posted date | Aug 29, 2002 |
| Issuing office | Los Angeles District Office |
| Product type | Drugs |
| CFR sections cited | 211.198, 211.165(a), 211.100(a), 211.84(d)(1), 211.22, 211.68, 211.166 |
| Country | 3 |
| Inspection city | Chandler |
| Inspection ZIP | 85224-5663 |
| Inspection start date | Apr 23, 2002 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: